Last reviewed · How we verify
NCT06871462: INSPIRED
Implementation Strategies for Self-Measured Blood Pressure Monitoring in Racially and Ethnically Diverse Populations
NA trial testing BP monitor use training and app training in Blood Pressure Monitoring, Home in 330 participants. Enrolling by invitation.
1 November 2027
Quick facts
| Lead sponsor | University of California, San Francisco |
|---|---|
| Phase | NA |
| Status | ENROLLING BY INVITATION |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 330 |
| Start date | 1 May 2025 |
| Primary completion | 1 November 2027 |
| Estimated completion | 1 May 2028 |
| Sites | 1 location across United States |
Drugs / interventions tested
- BP monitor use training and app training
- Online patient portal enrollment and training
- SMS reminders to take blood pressure
- Education about self-management of hypertension
- Educational text messages that encourage seeking support from a support person
- Involvement of caregiver or support person
- Group classes
Conditions studied
- Blood Pressure Monitoring, Home — all drugs for Blood Pressure Monitoring, Home →
- Hypertension — all drugs for Hypertension →
Sponsor
University of California, San Francisco
Who can join
18 and older, any sex, with Blood Pressure Monitoring, Home or Hypertension. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This clinical trial aims to assess the impact of patient-focused and clinical-focused implementation strategies on blood pressure control. The investigators will assess the costs of these strategies and how effective they were at safely and equitably increasing home blood pressure monitoring.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Implementation Strategies for Self-Measured Blood Pressure Monitoring in Racially and Ethnically Diverse Populations (InSPIRED): A study protocol.
Khoong EC, Kim HC, Li J, Larreynaga J, et al · · 2025 · PMID 41057081 · DOI 10.1016/j.cct.2025.108101
Verify or expand the search:
- PubMed search for NCT06871462
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Blood Pressure Monitoring, Home
Currently open trials in the same condition.
- NCT06394934 — Home Blood Pressure Variability and Its Link to Arteriosclerosis and Metabolic Dysfunction in Hypertensive Patients · recruiting
Other University of California, San Francisco trials
Trials by the same sponsor.
- NCT05284773 — Screening for Acute Malnutrition · NA · withdrawn
- NCT04634851 — Video Home Visits for Dietary Counselling · NA · not yet recruiting
- NCT06065670 — Assessing Changes in Multi-parametric MRI in Patients With Acute Demyelinating Lesions Taking Clemastine Fumarate as a M · Phase 1, PHASE2 · not yet recruiting
- NCT07534098 — Intervention for Hearing Health Among Native Americans · NA · not yet recruiting
- NCT06960421 — Exercise-based Frailty Intervention in Lung Transplantation (XFIT) · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06871462 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of California, San Francisco
- Last refreshed: 5 February 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06871462.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing